|
Name |
[(1S,6R)-2,5-dioxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methyl acetate
|
| Molecular Formula | C24H32O5 | |
| IUPAC Name* |
[(1S,6R)-2,5-dioxo-6-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]-7-oxabicyclo[4.1.0]hept-3-en-3-yl]methyl acetate
|
|
| SMILES |
CC(=CCC/C(=C/CC/C(=C/C[C@]12[C@H](O1)C(=O)C(=CC2=O)COC(=O)C)/C)/C)C
|
|
| InChI |
InChI=1S/C24H32O5/c1-16(2)8-6-9-17(3)10-7-11-18(4)12-13-24-21(26)14-20(15-28-19(5)25)22(27)23(24)29-24/h8,10,12,14,23H,6-7,9,11,13,15H2,1-5H3/b17-10+,18-12+/t23-,24+/m1/s1
|
|
| InChIKey |
ZNJXRPDYPGYTCI-QCZFUNBTSA-N
|
|
| Synonyms |
Yanuthone B
|
|
| CAS | NA | |
| PubChem CID | 101089578 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 400.5 | ALogp: | 4.8 |
| HBD: | 0 | HBA: | 5 |
| Rotatable Bonds: | 11 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 73.0 | Aromatic Rings: | 2 |
| Heavy Atoms: | 29 | QED Weighted: | 0.292 |
| Caco-2 Permeability: | -4.844 | MDCK Permeability: | 0.00002670 |
| Pgp-inhibitor: | 0.919 | Pgp-substrate: | 0.065 |
| Human Intestinal Absorption (HIA): | 0.048 | 20% Bioavailability (F20%): | 0.166 |
| 30% Bioavailability (F30%): | 0.251 |
| Blood-Brain-Barrier Penetration (BBB): | 0.876 | Plasma Protein Binding (PPB): | 84.96% |
| Volume Distribution (VD): | 0.864 | Fu: | 14.75% |
| CYP1A2-inhibitor: | 0.049 | CYP1A2-substrate: | 0.072 |
| CYP2C19-inhibitor: | 0.732 | CYP2C19-substrate: | 0.201 |
| CYP2C9-inhibitor: | 0.663 | CYP2C9-substrate: | 0.102 |
| CYP2D6-inhibitor: | 0.296 | CYP2D6-substrate: | 0.052 |
| CYP3A4-inhibitor: | 0.632 | CYP3A4-substrate: | 0.288 |
| Clearance (CL): | 5.114 | Half-life (T1/2): | 0.62 |
| hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.872 |
| Drug-inuced Liver Injury (DILI): | 0.559 | AMES Toxicity: | 0.922 |
| Rat Oral Acute Toxicity: | 0.009 | Maximum Recommended Daily Dose: | 0.655 |
| Skin Sensitization: | 0.966 | Carcinogencity: | 0.15 |
| Eye Corrosion: | 0.042 | Eye Irritation: | 0.293 |
| Respiratory Toxicity: | 0.487 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC003714 | ![]() |
0.743 | D09XWD | ![]() |
0.440 | ||
| ENC001464 | ![]() |
0.566 | D03VFL | ![]() |
0.414 | ||
| ENC001465 | ![]() |
0.512 | D05XQE | ![]() |
0.404 | ||
| ENC001466 | ![]() |
0.512 | D01ZUA | ![]() |
0.248 | ||
| ENC001462 | ![]() |
0.452 | D06BLQ | ![]() |
0.213 | ||
| ENC001096 | ![]() |
0.452 | D0X7XG | ![]() |
0.203 | ||
| ENC006119 | ![]() |
0.439 | D0OL7F | ![]() |
0.202 | ||
| ENC001716 | ![]() |
0.421 | D09SIK | ![]() |
0.202 | ||
| ENC002413 | ![]() |
0.419 | D0L2UN | ![]() |
0.201 | ||
| ENC001717 | ![]() |
0.419 | D04FBR | ![]() |
0.194 | ||